GLUE•benzinga•
Monte Rosa Therapeutics Will Present Preclinical Data At Digestive Disease Week 2024. Data Showed That MRT-6160-mediated Degradation Of VAV1 Inhibited Disease Progression In A T-Cell Transfer Murine Model Of Colitis
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 21, 2024 by benzinga